These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3286083)

  • 21. Single-dose pharmacokinetics of aztreonam in healthy volunteers and renal failure patients.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    J Chemother; 1989 Jun; 1(3):164-9. PubMed ID: 2795125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
    Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
    Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics of vancomycin.
    Matzke GR; Zhanel GG; Guay DR
    Clin Pharmacokinet; 1986; 11(4):257-82. PubMed ID: 3530582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aztreonam: clinical pharmacology.
    Stutman HR
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S104-8; discussion S128-32. PubMed ID: 2682507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of ketanserin.
    Persson B; Heykants J; Hedner T
    Clin Pharmacokinet; 1991 Apr; 20(4):263-79. PubMed ID: 2036747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group].
    Matsuda S; Oh K; Hirayama H; Shimizu T; Sengoku K; Haga H; Inoue R; Yamazaki T; Mizoguchi H; Tori-i Y
    Jpn J Antibiot; 1990 Apr; 43(4):736-53. PubMed ID: 2199691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic implications for the clinical use of propofol.
    Kanto J; Gepts E
    Clin Pharmacokinet; 1989 Nov; 17(5):308-26. PubMed ID: 2684471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsis.
    Winslade NE; Smith IL; Simons GW; Swanson DJ; Vigano A; Wels PB; Schentag JJ
    Rev Infect Dis; 1985; 7 Suppl 4():S716-23. PubMed ID: 3909329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of aztreonam and penetration into the bronchial secretions of critically ill patients.
    Boccazzi A; Langer M; Mandelli M; Ranzi AM; Urso R
    J Antimicrob Chemother; 1989 Mar; 23(3):401-7. PubMed ID: 2732121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aztreonam pharmacokinetics in burn patients.
    Friedrich LV; White RL; Kays MB; Brundage DM; Yarbrough D
    Antimicrob Agents Chemother; 1991 Jan; 35(1):57-61. PubMed ID: 2014982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of aztreonam in neonates].
    Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1990 Mar; 43(3):445-54. PubMed ID: 2374296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How and why aztreonam works.
    Rittenbury MS
    Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of cefotetan.
    Martin C; Thomachot L; Albanese J
    Clin Pharmacokinet; 1994 Apr; 26(4):248-58. PubMed ID: 8013159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of aztreonam in infected patients.
    Mattie H; Matze-van der Lans A
    J Antimicrob Chemother; 1986 Feb; 17(2):215-9. PubMed ID: 3700287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and pharmacokinetic evaluation of aztreonam in neonates].
    Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M; Oka T; Yoshioka H; Hiramoto A; Mori Y; Maruyama S
    Jpn J Antibiot; 1990 Mar; 43(3):388-95. PubMed ID: 2374291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of aztreonam in patients with gram-negative infections.
    Janicke DM; Cafarell RF; Parker SW; Apicella MA; Jusko WJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):16-20. PubMed ID: 4039117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the clinical pharmacology of the monobactam antibiotic aztreonam.
    Swabb EA
    Am J Med; 1985 Feb; 78(2A):11-8. PubMed ID: 3881946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.